The global market for Recombinant Human Interleukin-2 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Recombinant Human Interleukin-2 (IL-2) is a therapeutic protein used in medicine, particularly in immunotherapy. Interleukin-2 is a naturally occurring cytokine produced by activated T cells, and it plays a crucial role in regulating the immune response. Recombinant IL-2 is produced through genetic engineering techniques, where the IL-2 gene is inserted into host cells (such as bacteria, yeast, or mammalian cells) to produce large quantities of the protein.

North American market for Recombinant Human Interleukin-2 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Recombinant Human Interleukin-2 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Recombinant Human Interleukin-2 include Cytiva, Bio-Techne, Lonza, Sartorius CellGenix, Thermo Fisher Scientific, Miltenyi Biotec, Akron Biotech, Sino Biological, Creative Bioarray, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Interleukin-2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Interleukin-2.

The Recombinant Human Interleukin-2 market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human Interleukin-2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Human Interleukin-2 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Human Interleukin-2 Market Report

Report Metric	Details
Report Name	Recombinant Human Interleukin-2 Market
Segment by Type	Pharmaceutical Grade Other
Segment by Application	Medical Culture Medium Supplement Scientific Research
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Cytiva, Bio-Techne, Lonza, Sartorius CellGenix, Thermo Fisher Scientific, Miltenyi Biotec, Akron Biotech, Sino Biological, Creative Bioarray
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Interleukin-2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Interleukin-2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Recombinant Human Interleukin-2 Market report?

Ans: The main players in the Recombinant Human Interleukin-2 Market are Cytiva, Bio-Techne, Lonza, Sartorius CellGenix, Thermo Fisher Scientific, Miltenyi Biotec, Akron Biotech, Sino Biological, Creative Bioarray

What are the Application segmentation covered in the Recombinant Human Interleukin-2 Market report?

Ans: The Applications covered in the Recombinant Human Interleukin-2 Market report are Medical, Culture Medium Supplement, Scientific Research

What are the Type segmentation covered in the Recombinant Human Interleukin-2 Market report?

Ans: The Types covered in the Recombinant Human Interleukin-2 Market report are Pharmaceutical Grade, Other

1 Recombinant Human Interleukin-2 Market Overview

1.1 Product Definition

1.2 Recombinant Human Interleukin-2 by Type

1.2.1 Global Recombinant Human Interleukin-2 Market Value Comparison by Type (2024 VS 2031)

1.2.2 Pharmaceutical Grade

1.2.3 Other

1.3 Recombinant Human Interleukin-2 by Application

1.3.1 Global Recombinant Human Interleukin-2 Market Value by Application (2024 VS 2031)

1.3.2 Medical

1.3.3 Culture Medium Supplement

1.3.4 Scientific Research

1.4 Global Recombinant Human Interleukin-2 Market Size Estimates and Forecasts

1.4.1 Global Recombinant Human Interleukin-2 Revenue 2020-2031

1.4.2 Global Recombinant Human Interleukin-2 Sales 2020-2031

1.4.3 Global Recombinant Human Interleukin-2 Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Recombinant Human Interleukin-2 Market Competition by Manufacturers

2.1 Global Recombinant Human Interleukin-2 Sales Market Share by Manufacturers (2020-2025)

2.2 Global Recombinant Human Interleukin-2 Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Recombinant Human Interleukin-2 Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Recombinant Human Interleukin-2, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Recombinant Human Interleukin-2, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Recombinant Human Interleukin-2, Product Type & Application

2.7 Global Key Manufacturers of Recombinant Human Interleukin-2, Date of Enter into This Industry

2.8 Global Recombinant Human Interleukin-2 Market Competitive Situation and Trends

2.8.1 Global Recombinant Human Interleukin-2 Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Recombinant Human Interleukin-2 Players Market Share by Revenue

2.8.3 Global Recombinant Human Interleukin-2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Recombinant Human Interleukin-2 Market Scenario by Region

3.1 Global Recombinant Human Interleukin-2 Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Recombinant Human Interleukin-2 Sales by Region: 2020-2031

3.2.1 Global Recombinant Human Interleukin-2 Sales by Region: 2020-2025

3.2.2 Global Recombinant Human Interleukin-2 Sales by Region: 2026-2031

3.3 Global Recombinant Human Interleukin-2 Revenue by Region: 2020-2031

3.3.1 Global Recombinant Human Interleukin-2 Revenue by Region: 2020-2025

3.3.2 Global Recombinant Human Interleukin-2 Revenue by Region: 2026-2031

3.4 North America Recombinant Human Interleukin-2 Market Facts & Figures by Country

3.4.1 North America Recombinant Human Interleukin-2 Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Recombinant Human Interleukin-2 Sales by Country (2020-2031)

3.4.3 North America Recombinant Human Interleukin-2 Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Recombinant Human Interleukin-2 Market Facts & Figures by Country

3.5.1 Europe Recombinant Human Interleukin-2 Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Recombinant Human Interleukin-2 Sales by Country (2020-2031)

3.5.3 Europe Recombinant Human Interleukin-2 Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Recombinant Human Interleukin-2 Market Facts & Figures by Region

3.6.1 Asia Pacific Recombinant Human Interleukin-2 Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Recombinant Human Interleukin-2 Sales by Region (2020-2031)

3.6.3 Asia Pacific Recombinant Human Interleukin-2 Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Recombinant Human Interleukin-2 Market Facts & Figures by Country

3.7.1 Latin America Recombinant Human Interleukin-2 Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Recombinant Human Interleukin-2 Sales by Country (2020-2031)

3.7.3 Latin America Recombinant Human Interleukin-2 Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Recombinant Human Interleukin-2 Market Facts & Figures by Country

3.8.1 Middle East and Africa Recombinant Human Interleukin-2 Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Recombinant Human Interleukin-2 Sales by Country (2020-2031)

3.8.3 Middle East and Africa Recombinant Human Interleukin-2 Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Recombinant Human Interleukin-2 Sales by Type (2020-2031)

4.1.1 Global Recombinant Human Interleukin-2 Sales by Type (2020-2025)

4.1.2 Global Recombinant Human Interleukin-2 Sales by Type (2026-2031)

4.1.3 Global Recombinant Human Interleukin-2 Sales Market Share by Type (2020-2031)

4.2 Global Recombinant Human Interleukin-2 Revenue by Type (2020-2031)

4.2.1 Global Recombinant Human Interleukin-2 Revenue by Type (2020-2025)

4.2.2 Global Recombinant Human Interleukin-2 Revenue by Type (2026-2031)

4.2.3 Global Recombinant Human Interleukin-2 Revenue Market Share by Type (2020-2031)

4.3 Global Recombinant Human Interleukin-2 Price by Type (2020-2031)

5 Segment by Application

5.1 Global Recombinant Human Interleukin-2 Sales by Application (2020-2031)

5.1.1 Global Recombinant Human Interleukin-2 Sales by Application (2020-2025)

5.1.2 Global Recombinant Human Interleukin-2 Sales by Application (2026-2031)

5.1.3 Global Recombinant Human Interleukin-2 Sales Market Share by Application (2020-2031)

5.2 Global Recombinant Human Interleukin-2 Revenue by Application (2020-2031)

5.2.1 Global Recombinant Human Interleukin-2 Revenue by Application (2020-2025)

5.2.2 Global Recombinant Human Interleukin-2 Revenue by Application (2026-2031)

5.2.3 Global Recombinant Human Interleukin-2 Revenue Market Share by Application (2020-2031)

5.3 Global Recombinant Human Interleukin-2 Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Cytiva

6.1.1 Cytiva Company Information

6.1.2 Cytiva Description and Business Overview

6.1.3 Cytiva Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Cytiva Recombinant Human Interleukin-2 Product Portfolio

6.1.5 Cytiva Recent Developments/Updates

6.2 Bio-Techne

6.2.1 Bio-Techne Company Information

6.2.2 Bio-Techne Description and Business Overview

6.2.3 Bio-Techne Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Bio-Techne Recombinant Human Interleukin-2 Product Portfolio

6.2.5 Bio-Techne Recent Developments/Updates

6.3 Lonza

6.3.1 Lonza Company Information

6.3.2 Lonza Description and Business Overview

6.3.3 Lonza Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Lonza Recombinant Human Interleukin-2 Product Portfolio

6.3.5 Lonza Recent Developments/Updates

6.4 Sartorius CellGenix

6.4.1 Sartorius CellGenix Company Information

6.4.2 Sartorius CellGenix Description and Business Overview

6.4.3 Sartorius CellGenix Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Sartorius CellGenix Recombinant Human Interleukin-2 Product Portfolio

6.4.5 Sartorius CellGenix Recent Developments/Updates

6.5 Thermo Fisher Scientific

6.5.1 Thermo Fisher Scientific Company Information

6.5.2 Thermo Fisher Scientific Description and Business Overview

6.5.3 Thermo Fisher Scientific Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Thermo Fisher Scientific Recombinant Human Interleukin-2 Product Portfolio

6.5.5 Thermo Fisher Scientific Recent Developments/Updates

6.6 Miltenyi Biotec

6.6.1 Miltenyi Biotec Company Information

6.6.2 Miltenyi Biotec Description and Business Overview

6.6.3 Miltenyi Biotec Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Miltenyi Biotec Recombinant Human Interleukin-2 Product Portfolio

6.6.5 Miltenyi Biotec Recent Developments/Updates

6.7 Akron Biotech

6.7.1 Akron Biotech Company Information

6.7.2 Akron Biotech Description and Business Overview

6.7.3 Akron Biotech Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Akron Biotech Recombinant Human Interleukin-2 Product Portfolio

6.7.5 Akron Biotech Recent Developments/Updates

6.8 Sino Biological

6.8.1 Sino Biological Company Information

6.8.2 Sino Biological Description and Business Overview

6.8.3 Sino Biological Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sino Biological Recombinant Human Interleukin-2 Product Portfolio

6.8.5 Sino Biological Recent Developments/Updates

6.9 Creative Bioarray

6.9.1 Creative Bioarray Company Information

6.9.2 Creative Bioarray Description and Business Overview

6.9.3 Creative Bioarray Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Creative Bioarray Recombinant Human Interleukin-2 Product Portfolio

6.9.5 Creative Bioarray Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Recombinant Human Interleukin-2 Industry Chain Analysis

7.2 Recombinant Human Interleukin-2 Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Recombinant Human Interleukin-2 Production Mode & Process Analysis

7.4 Recombinant Human Interleukin-2 Sales and Marketing

7.4.1 Recombinant Human Interleukin-2 Sales Channels

7.4.2 Recombinant Human Interleukin-2 Distributors

7.5 Recombinant Human Interleukin-2 Customer Analysis

8 Recombinant Human Interleukin-2 Market Dynamics

8.1 Recombinant Human Interleukin-2 Industry Trends

8.2 Recombinant Human Interleukin-2 Market Drivers

8.3 Recombinant Human Interleukin-2 Market Challenges

8.4 Recombinant Human Interleukin-2 Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

List of Tables

Table 1. Global Recombinant Human Interleukin-2 Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Recombinant Human Interleukin-2 Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Recombinant Human Interleukin-2 Market Competitive Situation by Manufacturers in 2024

Table 4. Global Recombinant Human Interleukin-2 Sales (kg) of Key Manufacturers (2020-2025)

Table 5. Global Recombinant Human Interleukin-2 Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Recombinant Human Interleukin-2 Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Recombinant Human Interleukin-2 Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Recombinant Human Interleukin-2 Average Price (US$/g) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Recombinant Human Interleukin-2, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Recombinant Human Interleukin-2, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Recombinant Human Interleukin-2, Product Type & Application

Table 12. Global Key Manufacturers of Recombinant Human Interleukin-2, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Recombinant Human Interleukin-2 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Interleukin-2 as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Recombinant Human Interleukin-2 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Recombinant Human Interleukin-2 Sales by Region (2020-2025) & (kg)

Table 18. Global Recombinant Human Interleukin-2 Sales Market Share by Region (2020-2025)

Table 19. Global Recombinant Human Interleukin-2 Sales by Region (2026-2031) & (kg)

Table 20. Global Recombinant Human Interleukin-2 Sales Market Share by Region (2026-2031)

Table 21. Global Recombinant Human Interleukin-2 Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Recombinant Human Interleukin-2 Revenue Market Share by Region (2020-2025)

Table 23. Global Recombinant Human Interleukin-2 Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Recombinant Human Interleukin-2 Revenue Market Share by Region (2026-2031)

Table 25. North America Recombinant Human Interleukin-2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Recombinant Human Interleukin-2 Sales by Country (2020-2025) & (kg)

Table 27. North America Recombinant Human Interleukin-2 Sales by Country (2026-2031) & (kg)

Table 28. North America Recombinant Human Interleukin-2 Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Recombinant Human Interleukin-2 Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Recombinant Human Interleukin-2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Recombinant Human Interleukin-2 Sales by Country (2020-2025) & (kg)

Table 32. Europe Recombinant Human Interleukin-2 Sales by Country (2026-2031) & (kg)

Table 33. Europe Recombinant Human Interleukin-2 Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Recombinant Human Interleukin-2 Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Recombinant Human Interleukin-2 Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Recombinant Human Interleukin-2 Sales by Region (2020-2025) & (kg)

Table 37. Asia Pacific Recombinant Human Interleukin-2 Sales by Region (2026-2031) & (kg)

Table 38. Asia Pacific Recombinant Human Interleukin-2 Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Recombinant Human Interleukin-2 Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Recombinant Human Interleukin-2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Recombinant Human Interleukin-2 Sales by Country (2020-2025) & (kg)

Table 42. Latin America Recombinant Human Interleukin-2 Sales by Country (2026-2031) & (kg)

Table 43. Latin America Recombinant Human Interleukin-2 Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Recombinant Human Interleukin-2 Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Recombinant Human Interleukin-2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Recombinant Human Interleukin-2 Sales by Country (2020-2025) & (kg)

Table 47. Middle East and Africa Recombinant Human Interleukin-2 Sales by Country (2026-2031) & (kg)

Table 48. Middle East and Africa Recombinant Human Interleukin-2 Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Recombinant Human Interleukin-2 Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Recombinant Human Interleukin-2 Sales (kg) by Type (2020-2025)

Table 51. Global Recombinant Human Interleukin-2 Sales (kg) by Type (2026-2031)

Table 52. Global Recombinant Human Interleukin-2 Sales Market Share by Type (2020-2025)

Table 53. Global Recombinant Human Interleukin-2 Sales Market Share by Type (2026-2031)

Table 54. Global Recombinant Human Interleukin-2 Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Recombinant Human Interleukin-2 Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Recombinant Human Interleukin-2 Revenue Market Share by Type (2020-2025)

Table 57. Global Recombinant Human Interleukin-2 Revenue Market Share by Type (2026-2031)

Table 58. Global Recombinant Human Interleukin-2 Price (US$/g) by Type (2020-2025)

Table 59. Global Recombinant Human Interleukin-2 Price (US$/g) by Type (2026-2031)

Table 60. Global Recombinant Human Interleukin-2 Sales (kg) by Application (2020-2025)

Table 61. Global Recombinant Human Interleukin-2 Sales (kg) by Application (2026-2031)

Table 62. Global Recombinant Human Interleukin-2 Sales Market Share by Application (2020-2025)

Table 63. Global Recombinant Human Interleukin-2 Sales Market Share by Application (2026-2031)

Table 64. Global Recombinant Human Interleukin-2 Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Recombinant Human Interleukin-2 Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Recombinant Human Interleukin-2 Revenue Market Share by Application (2020-2025)

Table 67. Global Recombinant Human Interleukin-2 Revenue Market Share by Application (2026-2031)

Table 68. Global Recombinant Human Interleukin-2 Price (US$/g) by Application (2020-2025)

Table 69. Global Recombinant Human Interleukin-2 Price (US$/g) by Application (2026-2031)

Table 70. Cytiva Company Information

Table 71. Cytiva Description and Business Overview

Table 72. Cytiva Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 73. Cytiva Recombinant Human Interleukin-2 Product

Table 74. Cytiva Recent Developments/Updates

Table 75. Bio-Techne Company Information

Table 76. Bio-Techne Description and Business Overview

Table 77. Bio-Techne Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 78. Bio-Techne Recombinant Human Interleukin-2 Product

Table 79. Bio-Techne Recent Developments/Updates

Table 80. Lonza Company Information

Table 81. Lonza Description and Business Overview

Table 82. Lonza Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 83. Lonza Recombinant Human Interleukin-2 Product

Table 84. Lonza Recent Developments/Updates

Table 85. Sartorius CellGenix Company Information

Table 86. Sartorius CellGenix Description and Business Overview

Table 87. Sartorius CellGenix Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 88. Sartorius CellGenix Recombinant Human Interleukin-2 Product

Table 89. Sartorius CellGenix Recent Developments/Updates

Table 90. Thermo Fisher Scientific Company Information

Table 91. Thermo Fisher Scientific Description and Business Overview

Table 92. Thermo Fisher Scientific Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 93. Thermo Fisher Scientific Recombinant Human Interleukin-2 Product

Table 94. Thermo Fisher Scientific Recent Developments/Updates

Table 95. Miltenyi Biotec Company Information

Table 96. Miltenyi Biotec Description and Business Overview

Table 97. Miltenyi Biotec Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 98. Miltenyi Biotec Recombinant Human Interleukin-2 Product

Table 99. Miltenyi Biotec Recent Developments/Updates

Table 100. Akron Biotech Company Information

Table 101. Akron Biotech Description and Business Overview

Table 102. Akron Biotech Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 103. Akron Biotech Recombinant Human Interleukin-2 Product

Table 104. Akron Biotech Recent Developments/Updates

Table 105. Sino Biological Company Information

Table 106. Sino Biological Description and Business Overview

Table 107. Sino Biological Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 108. Sino Biological Recombinant Human Interleukin-2 Product

Table 109. Sino Biological Recent Developments/Updates

Table 110. Creative Bioarray Company Information

Table 111. Creative Bioarray Description and Business Overview

Table 112. Creative Bioarray Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 113. Creative Bioarray Recombinant Human Interleukin-2 Product

Table 114. Creative Bioarray Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Recombinant Human Interleukin-2 Distributors List

Table 118. Recombinant Human Interleukin-2 Customers List

Table 119. Recombinant Human Interleukin-2 Market Trends

Table 120. Recombinant Human Interleukin-2 Market Drivers

Table 121. Recombinant Human Interleukin-2 Market Challenges

Table 122. Recombinant Human Interleukin-2 Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Recombinant Human Interleukin-2

Figure 2. Global Recombinant Human Interleukin-2 Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Recombinant Human Interleukin-2 Market Share by Type: 2024 & 2031

Figure 4. Pharmaceutical Grade Product Picture

Figure 5. Other Product Picture

Figure 6. Global Recombinant Human Interleukin-2 Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Recombinant Human Interleukin-2 Market Share by Application: 2024 & 2031

Figure 8. Medical

Figure 9. Culture Medium Supplement

Figure 10. Scientific Research

Figure 11. Global Recombinant Human Interleukin-2 Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Recombinant Human Interleukin-2 Market Size (2020-2031) & (US$ Million)

Figure 13. Global Recombinant Human Interleukin-2 Sales (2020-2031) & (kg)

Figure 14. Global Recombinant Human Interleukin-2 Average Price (US$/g) & (2020-2031)

Figure 15. Recombinant Human Interleukin-2 Report Years Considered

Figure 16. Recombinant Human Interleukin-2 Sales Share by Manufacturers in 2024

Figure 17. Global Recombinant Human Interleukin-2 Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Recombinant Human Interleukin-2 Players: Market Share by Revenue in Recombinant Human Interleukin-2 in 2024

Figure 19. Recombinant Human Interleukin-2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Recombinant Human Interleukin-2 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Recombinant Human Interleukin-2 Sales Market Share by Country (2020-2031)

Figure 22. North America Recombinant Human Interleukin-2 Revenue Market Share by Country (2020-2031)

Figure 23. United States Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Recombinant Human Interleukin-2 Sales Market Share by Country (2020-2031)

Figure 26. Europe Recombinant Human Interleukin-2 Revenue Market Share by Country (2020-2031)

Figure 27. Germany Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Recombinant Human Interleukin-2 Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Recombinant Human Interleukin-2 Revenue Market Share by Region (2020-2031)

Figure 34. China Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Recombinant Human Interleukin-2 Sales Market Share by Country (2020-2031)

Figure 42. Latin America Recombinant Human Interleukin-2 Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Recombinant Human Interleukin-2 Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Recombinant Human Interleukin-2 Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Recombinant Human Interleukin-2 Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Recombinant Human Interleukin-2 by Type (2020-2031)

Figure 53. Global Revenue Market Share of Recombinant Human Interleukin-2 by Type (2020-2031)

Figure 54. Global Recombinant Human Interleukin-2 Price (US$/g) by Type (2020-2031)

Figure 55. Global Sales Market Share of Recombinant Human Interleukin-2 by Application (2020-2031)

Figure 56. Global Revenue Market Share of Recombinant Human Interleukin-2 by Application (2020-2031)

Figure 57. Global Recombinant Human Interleukin-2 Price (US$/g) by Application (2020-2031)

Figure 58. Recombinant Human Interleukin-2 Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global GMP Interleukin Market Insights Forecast to 2030

Proleukin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cytokines Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Recombinant Cytokines Drug Market Insights Forecast to 2030

Global Cytokines as Cell Culture Supplements Market Research Report 2024

Recombinant Interferon Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Interleukin 2 for Injection Market Research Report 2025

Global IL 4Rα Targeting Drugs Market Research Report 2024

Interferon Alpha 2a Biosimilar Market

Global Human Interleukin 2 IL 2 Market Research Report 2024

Global Interleukin 11 IL 11 Market Research Report 2024

Global α Interferon Market Research Report 2024

Global Long lasting Interferon Market Insights Forecast to 2030

Aldesleukin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global IL 4Rα Monoclonal Antibody Drug Market Research Report 2024

Interferon Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bovine Interleukin 2 IL2 ELISA Kit Market Research Report 2024

Global Anti Inflammatory Cytokine Market Research Report 2025

Global Culture Media Cytokines Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions